These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 8954141)
1. The neutrophil as an information transmitter in tumor inhibition by a streptococcal biological response modifier, OK-432. Sato T; Midorikawa Y; Yamashita T; Araki A; Sendo F Cancer Immunol Immunother; 1996 Oct; 43(2):77-86. PubMed ID: 8954141 [TBL] [Abstract][Full Text] [Related]
2. New approach to management of malignant ascites with streptococcal preparation OK-432. III. OK-432 attracts natural killer cells through a chemotactic factor released from activated neutrophils. Hayashi Y; Torisu M Surgery; 1990 Jan; 107(1):74-84. PubMed ID: 2404351 [TBL] [Abstract][Full Text] [Related]
3. Tumor cytotoxicity of peritoneal macrophages induced by OK-432. Huang Y; Xu Y; Yamagishi H; Hagiwara A Anticancer Drugs; 2001 Oct; 12(9):781-5. PubMed ID: 11593060 [TBL] [Abstract][Full Text] [Related]
4. [Antitumor effect of OK-432 (3)--mechanisms of tumor growth inhibition by OK-432 induced activated macrophages]. Nanjo M; Saito M; Aonuma E; Fujimura H; Nakamura T; Aso H; Yoshie O; Ebina T; Ishida N Gan To Kagaku Ryoho; 1985 Apr; 12(4):887-93. PubMed ID: 3885861 [TBL] [Abstract][Full Text] [Related]
5. Activation of omental milky spots and milky spot macrophages by intraperitoneal administration of a streptococcal preparation, OK-432. Shimotsuma M; Simpson-Morgan MW; Takahashi T; Hagiwara A Cancer Res; 1992 Oct; 52(19):5400-2. PubMed ID: 1394145 [TBL] [Abstract][Full Text] [Related]
6. Activation of macrophage function by intraperitoneal administration of the streptococcal antitumor agent OK-432. Kawaguchi T; Suematsu M; Koizumi HM; Mitsui H; Suzuki S; Matsuno T; Ogawa H; Nomoto K Immunopharmacology; 1983 Oct; 6(3):177-89. PubMed ID: 6629737 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of inflammatory infiltrates around the injection site of a streptococcal preparation, OK-432, in rat tongue. Niimi A; Shinoda T; Kaneda T; Nagura H Biotherapy; 1990; 2(1):13-20. PubMed ID: 2119200 [TBL] [Abstract][Full Text] [Related]
8. Enhanced adherence activity of OK-432-induced peritoneal neutrophils to tumor cells correlates to their increased expression of CD11b/CD18. Morisaki T; Torisu M Clin Immunol Immunopathol; 1991 Jun; 59(3):474-86. PubMed ID: 1674240 [TBL] [Abstract][Full Text] [Related]
9. Evidence that eosinophil infiltration in the OK-432/fibrinogen-injected Meth-A tumor in mice is mediated by locally produced IL-5. Ishiko T; Sakamoto K; Mita S; Kamohara H; Ogawa M Int J Immunopharmacol; 1997 Jul; 19(7):405-12. PubMed ID: 9568545 [TBL] [Abstract][Full Text] [Related]
10. Antitumor effect in peritoneal carcinomatosis of intraperitoneal administration of a streptococcal preparation, OK-432: I. Experimental study in the rat. Saji S; Umemoto T; Kida H; Sakata K J Surg Oncol; 1985 Sep; 30(1):46-51. PubMed ID: 4079418 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous intraperitoneal administration of OK-432 and serum enhances superoxide generation from migrated polymorphonuclear leukocytes, with special emphasis on the role of complements. Yoshikawa T; Takano H; Yoshida N; Kondo M Immunopharmacol Immunotoxicol; 1995 May; 17(2):265-82. PubMed ID: 7650290 [TBL] [Abstract][Full Text] [Related]
12. Activated macrophages are responsible for the tumor-inhibitory effect in mice receiving intravenous injection of OK-432. Saito M; Nanjo M; Aonuma E; Noda T; Nakadate I; Ebina T; Ishida N Int J Cancer; 1984 Feb; 33(2):271-6. PubMed ID: 6420351 [TBL] [Abstract][Full Text] [Related]
13. Activation of cytotoxic polymorphonuclear leukocytes by in vivo administration of a streptococcal preparation, OK-432. Watabe S; Sendo F; Kimura S; Arai S J Natl Cancer Inst; 1984 Jun; 72(6):1365-70. PubMed ID: 6587156 [TBL] [Abstract][Full Text] [Related]
14. In vivo antitumor effect of lymphokine-activated rodent polymorphonuclear leukocytes. Fujii Y; Kimura S; Arai S; Sendo F Cancer Res; 1987 Nov; 47(22):6000-5. PubMed ID: 3117360 [TBL] [Abstract][Full Text] [Related]
15. The biological response modifier OK-432 (a streptococcal preparation) inhibits the development of autoimmune kidney disease in NZB/W F1 hybrid mice: possible involvement of tumor necrosis factor. Mihara M; Ohsugi Y Int Arch Allergy Appl Immunol; 1989; 90(1):37-42. PubMed ID: 2807578 [TBL] [Abstract][Full Text] [Related]
16. Neutrophil-mediated tumor cell destruction in cancer ascites. II. A OK-432 attracts killer neutrophils through activation of complement C5. Fujimura T; Torisu M Clin Immunol Immunopathol; 1987 May; 43(2):174-84. PubMed ID: 3105938 [TBL] [Abstract][Full Text] [Related]
17. Treatment of cancer ascites by intraperitoneal administration of a streptococcal preparation OK-432 with fresh human complement--role of complement-derived chemotactic factor to neutrophils. Kondo M; Kato H; Yoshikawa T; Sugino S Int J Immunopharmacol; 1986; 8(7):715-21. PubMed ID: 3536766 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of the photodynamic antitumor effect by streptococcal preparation OK-432 in the mouse carcinoma. Uehara M; Sano K; Wang ZL; Sekine J; Ikeda H; Inokuchi T Cancer Immunol Immunother; 2000 Oct; 49(8):401-9. PubMed ID: 11043846 [TBL] [Abstract][Full Text] [Related]
19. New approach to management of malignant ascites with a streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destruction. Katano M; Torisu M Surgery; 1983 Mar; 93(3):365-73. PubMed ID: 6600854 [TBL] [Abstract][Full Text] [Related]
20. Stimulation of arachidonic acid metabolism by a streptococcal preparation (OK-432) in rat peritoneal macrophages. Watanabe M; Shishido Y; Hirasawa N; Mue S; Fujiki H; Ohuchi K Biochim Biophys Acta; 1992 Feb; 1138(2):157-61. PubMed ID: 1540662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]